Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

Miripla (miriplatin)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Sumitomo Pharma

Drug class:

DNA synthesis inhibitor, DNA cross linking agent

Related drugs:

‹

cisplatin (330)

gemcitabine (181)

temozolomide (114)

cytarabine (99)

oxaliplatin (57)

dacarbazine (22)

cytarabine/daunorubicin liposomal formulation (19)

clofarabine (16)

carmustine (14)

temozolomide gel (7)

fludarabine IV (6)

hydroxyurea (3)

mercaptopurine (3)

fotemustine (2)

streptozocin (2)

fludarabine oral (2)

thioguanine (2)

fosgemcitabine palabenamide (1)

asparagine cytarabine conjugate (1)

gemcitabine-releasing intravesical system (1)

mitomycin urothelial gel (1)

melphalan hepatic delivery system (1)

pegylated glutaminase/glutamine analog combination (0)

liposomal cisplatin (0)

pegylated liposomal mitomycin-c prodrug (0)

mercaptopurine oral suspension (0)

gemcitabine with RenovoCath (0)

cytarabine ocfosfate (0)

mitomycin intravesicular (0)

captisol-enabled melphalan (0)

idarubicin hydrochloride (16)

cisplatin liposomal (0)

demplatin pegraglumer (0)

›